Subcutaneous administration of live lactobacillus prevents sepsis-induced lung organ failure in rats
No Thumbnail Available
Date
2005
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The leading cause of death in intensive care units around the world is the syndrome of exaggerated and prolonged systemic inflammation response (SIRS), which if not controlled will lead to irreversible, often multiple, organ dysfunction and organ failure syndrome (MODS). Host phagocytic cells, predominantly macrophages and neutrophils, and their soluble products, play a central role. Accumulation of neutrophils is often observed, especially in the lungs, intestines, liver and kidneys. Neutrophilic infiltration of distant organs, and especially of the lungs, has been a characteristic finding of patients dying from sepsis. However, the mechanisms responsible for the exuberant inflammation and neutrophil infiltration are not yet fully understood. It has recently been demonstrated that this, at least in part, is due to an inhibition of neutrophil apoptosis, and there is a suggested association with activation of nuclear factor - κB (NF-κB), reduced activity of caspases-9 and -3 and maintenance of mitochondrial transmembrane potential.
Description
Keywords
immunoglobulin enhancer binding protein , myeloperoxidase , probiotic agent , animal model , animal tissue , apoptosis , article , controlled study , enzyme activity , enzyme assay , inflammation , intensive care unit , Lactobacillus , lung insufficiency , macrophage , male , membrane potential , mitochondrial membrane , neutrophil chemotaxis , nonhuman , phagocyte , rat , sepsis